It has plans to undertake clinical trials of rare disease treatments in the future.
Bo'ao Winhealth Rare Disease Medical Center has been officially launched in Hainan, jointly built by Hainan Bo'ao International Medical Tourism Pilot Zone Administration, Winhealth Pharma Group, and Bo'ao Worldlight Hospital.
Since clinching permit from Lecheng Administration, the centre has established cooperation with various experts and institutes for rare diseases, patient groups, and various domestic and overseas pharmaceutical companies.
The functions of the center include introducing advanced rare disease medicines and devices; providing high-end medical services; and cooperating with manufacturers, insurance companies, and other stakeholders to solve affordability issues.
It also plans to undertake real-world studies in the short term, and other clinical trials in the future to support registration of overseas rare disease products in China. It will also host and join in academic activities and patient group activities.
Do you know more about this story? Contact us anonymously through this link.